Ocular Looks To Kick Investor Suit Over Eye Drug Approval
Ocular Therapeutix Inc. and its executives moved Friday to toss a proposed investor class action alleging that the biopharmaceutical company misled them about receiving federal approval for an eye pain reliever,...To view the full article, register now.
Already a subscriber? Click here to view full article